Career Opportunities

Mucosis B.V. is an exciting, young Groningen-based Dutch biotech company developing innovative mucosal vaccines that are applied needle-free via the nose or mouth. Mucosis's lead product candidate is SynGEM®, an intranasal vaccine to prevent respiratory syncytial virus infections. Our vaccines are based on Mimopath®, a unique technology that enables a robust natural immune response as well as a broad base of protection.

Mucosis is searching for team players with relevant experience in biotech industry who share our passion for excellence. We are currently recruiting for the positions outlined below. If you are interested in joining our team, please submit a resume and cover letter to  info@mucosis.com.

Job Listings

QC Supervisor

 

24.03.16 Mucosis to Present at World Vaccines Congress 2016
more >

20.01.16 Mucosis Secures €3.7M from Wellcome Trust to Fund Clinical Trials of its Respiratory Syncytial Virus Vaccine in Partnership with Imperial College London
more >

19.05.15 Mucosis to Present Data on Intranasal RSV Vaccine SynGEM® at Modern Vaccines Adjuvants & Delivery Systems 2015
more >

23.03.15 Mucosis to Present on Intranasal Respiratory Syncytial Virus Vaccine Candidate SynGEM® at BioCapital Europe
more >

10.11.14 Mucosis Presents Data on Intranasal Respiratory Syncytial Virus Vaccine SynGEM® at RSV2014 Symposium
more >

20.10.14 Mucosis Presents Data on Intranasal RSV Vaccine SynGEM® at Vaccines 2014 Conference
more >

30.09.14 Mucosis Presents Infectious Diseases Vaccines Pipeline Update at SACHs Associates 14th Annual Biotech in Europe Forum
more >